0 results available. Select is focused ,type to refine list, press Down to open the menu,
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter...
We've identified the following companies as similar to Edwards Lifesciences Corp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Market Cap in the valuation category include:
Measures a public company's total equity value as implied by the stock's last observed trading price. In the case of cryptocurrencies, it measure the ...
Market capitalization or “market cap” is a public company’s total equity value as implied by the stock’s last observed trading price. Market Cap for Edwards Lifesciences is calculated as follows:
Stock Price Close [ 71.87 ]
(x) Shares Outstanding [ 587.9 ]
(=) Market Capitalization [ 42.252 B ]
The tables below summarizes the trend in Edwards Lifesciences’s market cap over the last five years:
| Date | Stock Price | Shares Outstanding | Market Cap |
|---|---|---|---|
| 2020-12-31 | 91.23 | 623.2 | 56.859 B |
| 2021-12-31 | 129.55 | 624.3 | 80.883 B |
| 2022-12-31 | 74.61 | 618.3 | 46.128 B |
| 2023-12-31 | 76.25 | 606.5 | 46.246 B |
| 2024-12-31 | 74.03 | 589.8 | 43.663 B |
The tables below summarizes the trend in Edwards Lifesciences’s market cap over the last four quarters:
| Date | Stock Price | Shares Outstanding | Market Cap |
|---|---|---|---|
| 2024-03-31 | 95.56 | 601.9 | 57.52 B |
| 2024-06-30 | 92.37 | 602.6 | 55.662 B |
| 2024-09-30 | 65.99 | 602.4 | 39.752 B |
| 2024-12-31 | 74.03 | 589.8 | 43.663 B |
The chart above depicts the distribution of market cap for companies operating in the Healthcare sector in the Developed economic region. Over 3,090 companies were considered in this analysis, and 2,971 had meaningful values. The average market cap of companies in the sector is 756.8 M with a standard deviation of 2.664 B.
Edwards Lifesciences Corp's Market Cap of 42.252 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,094 |
| Included Constituents | 2,971 |
| Min | 0.043 K |
| Max | 26.307 B |
| Median | 29.253 M |
| Mean | 756.8 M |
| Standard Deviation | 2.664 B |
You can find companies with similar market cap using this stock screener.